🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the makers of Tylenol, alleging the corporations concealed potential risks that the drug created to children's cognitive development.

This legal action comes four weeks after Former President Trump publicized an unverified association between taking acetaminophen - referred to as acetaminophen - while pregnant and autism spectrum disorder in young ones.

Paxton is taking legal action against J&J, which formerly manufactured the medication, the sole analgesic approved for women during pregnancy, and Kenvue, which now manufacturers it.

In a official comment, he said they "deceived the public by gaining financially from pain and promoting medication ignoring the dangers."

Kenvue says there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These companies deceived for years, knowingly endangering countless individuals to increase profits," Paxton, from the Republican party, declared.

The manufacturer stated officially that it was "deeply concerned by the perpetuation of misinformation on the reliability of acetaminophen and the likely effects that could have on the health of American women and children."

On its official site, the company also mentioned it had "regularly reviewed the pertinent research and there is no credible data that indicates a proven link between using paracetamol and autism."

Associations acting on behalf of physicians and healthcare providers share this view.

The leading OB-GYN organization has stated acetaminophen - the primary component in acetaminophen - is one of the few options for pregnant women to manage pain and fever, which can create major wellness concerns if ignored.

"In more than two decades of research on the consumption of acetaminophen in pregnancy, no reliable research has successfully concluded that the usage of paracetamol in any trimester of pregnancy leads to brain development issues in young ones," the association said.

The lawsuit references current declarations from the Trump administration in asserting the drug is allegedly unsafe.

Recently, the former president caused concern from public health officials when he told pregnant women to "struggle intensely" not to take acetaminophen when sick.

The US Food and Drug Administration then released a statement that physicians should think about restricting the use of Tylenol, while also declaring that "a proven link" between the drug and autism in young ones has not been established.

Health Secretary Robert F Kennedy Jr, who supervises the Food and Drug Administration, had promised in spring to initiate "a massive testing and research effort" that would determine the cause of autism in a short period.

But specialists warned that finding a unique factor of autism spectrum disorder - believed by scientists to be the result of a complicated interplay of inherited and external influences - would prove challenging.

Autism spectrum disorder is a form of permanent neurological difference and condition that affects how persons perceive and interact with the world, and is diagnosed using medical professional evaluations.

In his court filing, Paxton - aligned with the former president who is campaigning for US Senate - asserts Kenvue and J&J "deliberately disregarded and sought to suppress the research" around paracetamol and autism.

This legal action aims to force the companies "remove any marketing or advertising" that asserts Tylenol is safe for pregnant women.

The court case mirrors the grievances of a assembly of guardians of minors with autism and ADHD who sued the producers of Tylenol in two years ago.

The court dismissed the lawsuit, declaring research from the plaintiffs' authorities was inconclusive.